Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Singular Genomics Systems (OMIC)
NASDAQ:OMIC
RESEARCH TOOLSreports
Holding OMIC?
Track your performance easily
OMIC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.34 - $23.41
Previous Close$21.9
Volume10.61K
Average Volume (3M)107.46K
Market Cap
$55.01M
Enterprise Value-$8.33M
Total Cash (Recent Filing)$113.83M
Total Debt (Recent Filing)$50.49M
Price to Earnings (P/E)―
Beta4.23
Next Earnings
Feb 27, 2025EPS Estimate
-$8.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-34.92
Shares Outstanding2,511,783
10 Day Avg. Volume15,451
30 Day Avg. Volume107,459
Standard Deviation0.27
R-Squared0.07
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.44
Price to Sales (P/S)20.28
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.13
Enterprise Value/Gross Profit14.93
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Singular Genomics Systems News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OMIC FAQ
What was Singular Genomics Systems’s price range in the past 12 months?
Singular Genomics Systems lowest stock price was $5.34 and its highest was $23.41 in the past 12 months.
What is Singular Genomics Systems’s market cap?
Currently, no data Available
When is Singular Genomics Systems’s upcoming earnings report date?
Singular Genomics Systems’s upcoming earnings report date is Feb 27, 2025 which is in 96 days.
How were Singular Genomics Systems’s earnings last quarter?
Singular Genomics Systems released its earnings results on Nov 12, 2024. The company reported -$6.72 earnings per share for the quarter, beating the consensus estimate of -$8.24 by $1.52.
Is Singular Genomics Systems overvalued?
According to Wall Street analysts Singular Genomics Systems’s price is currently Overvalued.
Does Singular Genomics Systems pay dividends?
Singular Genomics Systems does not currently pay dividends.
What is Singular Genomics Systems’s EPS estimate?
Singular Genomics Systems’s EPS estimate is -$8.1.
How many shares outstanding does Singular Genomics Systems have?
Singular Genomics Systems has 2,511,783 shares outstanding.
What happened to Singular Genomics Systems’s price movement after its last earnings report?
Singular Genomics Systems reported an EPS of -$6.72 in its last earnings report, beating expectations of -$8.24. Following the earnings report the stock price went down -1.916%.
Which hedge fund is a major shareholder of Singular Genomics Systems?
Among the largest hedge funds holding Singular Genomics Systems’s share is Deerfield Management Company, LP. It holds Singular Genomics Systems’s shares valued at 3M.
---
Singular Genomics Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 20.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
77.18%
12-Months-Change
Fundamentals
Return on Equity
-53.57%
Trailing 12-Months
Asset Growth
-34.43%
Trailing 12-Months
Company Description
Singular Genomics Systems
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Integrated Solution is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
---
OMIC Earnings Call
Q2 2024
0:00 / 0:00
---
OMIC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---